StonvexLoading…
StonvexStonvexStonvexCore line items from PBH's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q3 2026 (Est.) Expected 2026-08-05 | Annual 2026 2026-03-31 | Q4 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $252.18M | $1.09B | $807.09M | $523.64M | $249.53M |
Operating Income | Not available | $309.41M | $233.92M | $151.43M | $71.76M |
Net Income | Not available | $190.30M | $136.37M | $89.68M | $47.47M |
EPS (Diluted) | $0.89 | $3.91 | $2.78 | $1.81 | $0.95 |
Total Assets | Not available | $3.49B | $3.49B | $3.44B | $3.43B |
Total Liabilities | Not available | $1.61B | $1.67B | $1.62B | $1.58B |
Cash & Equivalents | Not available | $63.87M | $62.37M | $119.11M | $139.50M |
Free Cash Flow OCF − CapEx | Not available | $246.45M | $208.82M | $133.56M | $78.17M |
Shares Outstanding | Not available | 48.72M | 49.06M | 49.55M | 49.83M |